logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • sanofi-aventis U.S. LLC drugs

    FiltersReset Filters
    27 results

    • admelog

      (insulin lispro)
      Sanofi-Aventis U.S. LLC
      Usage: ADMELOG is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

    • apidra

      (insulin glulisine)
      sanofi-aventis U.S. LLC
      Usage: APIDRA is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

    • arava - leflunomide tablet, film coated

      (Leflunomide)
      Sanofi-Aventis U.S. Llc

    • avalide - irbesartan and hydrochlorothiazide tablet, film coated

      (Irbesartan And Hydrochlorothiazide)
      Sanofi-Aventis U.S. Llc

    • avapro

      (irbesartan)
      Sanofi-Aventis U.S. LLC
      Usage: AVAPRO® is indicated for treating hypertension, reducing blood pressure to lower cardiovascular event risks, and for managing diabetic nephropathy in type 2 diabetes patients with hypertension and proteinuria. It may be used alone or with other antihypertensive agents to achieve blood pressure goals and protect kidney function.

    • docetaxel - docetaxel injection, solution, concentrate

      (Docetaxel)
      Sanofi-Aventis U.S. Llc

    • dupixent

      (Dupilumab)
      sanofi-aventis U.S. LLC
      Usage: DUPIXENT is indicated for treating moderate-to-severe atopic dermatitis in patients 6 months and older, asthma in patients 6 years and older, chronic rhinosinusitis with nasal polyps in patients 12 and older, eosinophilic esophagitis, prurigo nodularis, inadequate COPD management, chronic spontaneous urticaria over 12, and bullous pemphigoid in adults.

    • elitek

      (rasburicase)
      Sanofi-Aventis U.S. LLC
      Usage: Elitek is indicated for the initial management of elevated plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumors undergoing anticancer therapy that may cause tumor lysis. It is intended for a single course of treatment.

    • fexinidazole

      (Fexinidazole)
      Sanofi-Aventis U.S. LLC
      Usage: Fexinidazole Tablets are indicated for treating both first-stage and second-stage human African trypanosomiasis (HAT) caused by *Trypanosoma brucei gambiense* in patients aged 6 years and older, weighing at least 20 kg. Limited use is advised in severe second-stage HAT cases with high CSF-WBC counts.

    • insulin glargine u-300- insulin glargine injection, solution

      (Insulin Glargine)
      Sanofi-Aventis U.S. Llc